```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 212 Enrolled Bill (ENR)]

        H.R.212

                     One Hundred Fourteenth Congress

                                 of the

                        United States of America

                          AT THE FIRST SESSION

          Begun and held at the City of Washington on Tuesday,
           the sixth day of January, two thousand and fifteen

                                 An Act

 
 To amend the Safe Drinking Water Act to provide for the assessment and 
management of the risk of algal toxins in drinking water, and for other 
                                purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
    This Act may be cited as the ``Drinking Water Protection Act''.
SEC. 2. AMENDMENT TO THE SAFE DRINKING WATER ACT.
    (a) Amendment.--Part E of the Safe Drinking Water Act (42 U.S.C. 
300j et seq.) is amended by adding at the end the following new 
section:
``SEC. 1459. ALGAL TOXIN RISK ASSESSMENT AND MANAGEMENT.
    ``(a) Strategic Plan.--
        ``(1) Development.--Not later than 90 days after the date of 
    enactment of this section, the Administrator shall develop and 
    submit to Congress a strategic plan for assessing and managing 
    risks associated with algal toxins in drinking water provided by 
    public water systems. The strategic plan shall include steps and 
    timelines to--
            ``(A) evaluate the risk to human health from drinking water 
        provided by public water systems contaminated with algal 
        toxins;
            ``(B) establish, publish, and update a comprehensive list 
        of algal toxins which the Administrator determines may have an 
        adverse effect on human health when present in drinking water 
        provided by public water systems, taking into account likely 
        exposure levels;
            ``(C) summarize--
                ``(i) the known adverse human health effects of algal 
            toxins included on the list published under subparagraph 
            (B) when present in drinking water provided by public water 
            systems; and
                ``(ii) factors that cause toxin-producing cyanobacteria 
            and algae to proliferate and express toxins;
            ``(D) with respect to algal toxins included on the list 
        published under subparagraph (B), determine whether to--
                ``(i) publish health advisories pursuant to section 
            1412(b)(1)(F) for such algal toxins in drinking water 
            provided by public water systems;
                ``(ii) establish guidance regarding feasible analytical 
            methods to quantify the presence of algal toxins; and
                ``(iii) establish guidance regarding the frequency of 
            monitoring necessary to determine if such algal toxins are 
            present in drinking water provided by public water systems;
            ``(E) recommend feasible treatment options, including 
        procedures, equipment, and source water protection practices, 
        to mitigate any adverse public health effects of algal toxins 
        included on the list published under subparagraph (B); and
            ``(F) enter into cooperative agreements with, and provide 
        technical assistance to, affected States and public water 
        systems, as identified by the Administrator, for the purpose of 
        managing risks associated with algal toxins included on the 
        list published under subparagraph (B).
        ``(2) Updates.--The Administrator shall, as appropriate, update 
    and submit to Congress the strategic plan developed under paragraph 
    (1).
    ``(b) Information Coordination.--In carrying out this section the 
Administrator shall--
        ``(1) identify gaps in the Agency's understanding of algal 
    toxins, including--
            ``(A) the human health effects of algal toxins included on 
        the list published under subsection (a)(1)(B); and
            ``(B) methods and means of testing and monitoring for the 
        presence of harmful algal toxins in source water of, or 
        drinking water provided by, public water systems;
        ``(2) as appropriate, consult with--
            ``(A) other Federal agencies that--
                ``(i) examine or analyze cyanobacteria or algal toxins; 
            or
                ``(ii) address public health concerns related to 
            harmful algal blooms;
            ``(B) States;
            ``(C) operators of public water systems;
            ``(D) multinational agencies;
            ``(E) foreign governments;
            ``(F) research and academic institutions; and
            ``(G) companies that provide relevant drinking water 
        treatment options; and
        ``(3) assemble and publish information from each Federal agency 
    that has--
            ``(A) examined or analyzed cyanobacteria or algal toxins; 
        or
            ``(B) addressed public health concerns related to harmful 
        algal blooms.
    ``(c) Use of Science.--The Administrator shall carry out this 
section in accordance with the requirements described in section 
1412(b)(3)(A), as applicable.
    ``(d) Feasible.--For purposes of this section, the term `feasible' 
has the meaning given such term in section 1412(b)(4)(D).''.
    (b) Report to Congress.--Not later than 90 days after the date of 
enactment of this Act, the Comptroller General of the United States 
shall prepare and submit to Congress a report that includes--
        (1) an inventory of funds--
            (A) expended by the United States, for each of fiscal years 
        2010 through 2014, to examine or analyze toxin-producing 
        cyanobacteria and algae or address public health concerns 
        related to harmful algal blooms; and
            (B) that includes the specific purpose for which the funds 
        were made available, the law under which the funds were 
        authorized, and the Federal agency that received or spent the 
        funds; and
        (2) recommended steps to reduce any duplication, and improve 
    interagency coordination, of such expenditures.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
```